Your browser doesn't support javascript.
loading
Development and Evaluation of Self-Emulsifying Drug-Delivery System-Based Tablets for Simvastatin, a BCS Class II Drug.
Bashir, Muhammad Anwar; Khan, Amjad; Shah, Sayyed Ibrahim; Ullah, Majeed; Khuda, Fazli; Abbas, Muhammad; Goh, Khang Wen; Ming, Long Chiau.
Afiliación
  • Bashir MA; Department of Pharmacy, Abasyn University, Peshawar, Pakistan.
  • Khan A; Department of Pharmacy, Kohat University of Science and Technology, Kohat, Pakistan.
  • Shah SI; Department of Pharmacy, Abdul Wali Khan University, Mardan, Pakistan.
  • Ullah M; Department of Pharmacy, Kohat University of Science and Technology, Kohat, Pakistan.
  • Khuda F; Department of Pharmacy, University of Peshawar, Peshawar, Pakistan.
  • Abbas M; Department of Pharmacy, Abdul Wali Khan University, Mardan, Pakistan.
  • Goh KW; Faculty of Data Science and Information Technology, INTI International University, Nilai, Malaysia.
  • Ming LC; PAP Rashidah Sa'adatul Bolkiah Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, Brunei Darussalam.
Drug Des Devel Ther ; 17: 261-272, 2023.
Article en En | MEDLINE | ID: mdl-36726738
Background: Self-emulsifying drug-delivery systems (SEDDSs) are designed to improve the oral bioavailability of poorly water-soluble drugs. This study aimed at formulating and characterization of SEDDS-based tablets for simvastatin using castor and olive oils as solvents and Tween 60 as surfactant. Methods: The liquids were adsorbed on microcrystalline cellulose, and all developed formulations were compressed using 10.5 mm shallow concave round punches. Results: The resulting tablets were evaluated for different quality-control parameters at pre- and postcompression levels. Simvastatin showed better solubility in a mixture of oils and Tween 60 (10:1). All the developed formulations showed lower self-emulsification time (˂200 seconds) and higher cloud point (˃60°C). They were free of physical defects and had drug content within the acceptable range (98.5%-101%). The crushing strength of all formulations was in the range of 58-96 N, and the results of the friability test were within the range of USP (≤1). Disintegration time was within the official limits (NMT 15 min), and complete drug release was achieved within 30 min. Conclusion: Using commonly available excipients and machinery, SEDDS-based tablets with better dissolution profile and bioavailability can be prepared by direct compression. These S-SEDDSs could be a better alternative to conventional tablets of simvastatin.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polisorbatos / Simvastatina Idioma: En Revista: Drug Des Devel Ther Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Pakistán Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polisorbatos / Simvastatina Idioma: En Revista: Drug Des Devel Ther Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Pakistán Pais de publicación: Nueva Zelanda